We analyzed the relevance of HLA compatibility to sustained marrow engraftment in 269 patients with hematologic neoplasms who underwent bone marrow transplantations. Each patient received marrow from a family member who shared one HLA haplotype with the patient but differed to a variable degree for the HLA-A, B, and D antigens of the haplotype not shared. These 269 patients were compared with 930 patients who received marrow from siblings with identical HLA genotypes. All patients were treated with cyclophosphamide and total-body irradiation followed by the infusion of unmodified donor marrow cells. The rate of graft failure was 12.3 percent among the recipients of marrow from a donor with only one identical haplotype, as compared with 2.0 percent among recipients of marrow from a sibling with the same HLA genotype (both haplotypes inherited from the same parents) (P less than 0.0001). The incidence of graft failure correlated with the degree of donor HLA incompatibility. Graft failure occurred in 3 of 43 transplants (7 percent) from donors who were phenotypically HLA-matched with their recipient (haplotypes similar, but not inherited from the same parents), in 11 of 121 donors (9 percent) incompatible for one HLA locus, in 18 of 86 (21 percent) incompatible for two loci, and in 1 of 19 (5 percent) incompatible for three loci (P = 0.028). In a multivariate binary logistic regression analysis, independent risk factors associated with graft failure were donor incompatibility for HLA-B and D (relative risk = 2.1; 95 percent confidence interval, 1.7 to 2.5; P = 0.0004) and a positive crossmatch for anti-donor lymphocytotoxic antibody (relative risk = 2.3; 95 percent confidence interval, 1.8 to 2.8; P = 0.0038). Residual host lymphocytes were detected in 11 of 14 patients with graft failure, suggesting that the mechanism for graft failure could be host-mediated immune rejection. We conclude that donor HLA incompatibility and prior alloimmunization are significant risk factors for graft failure, and that a more effective immunosuppressive regimen than those currently used is needed for consistent achievement of sustained engraftment of marrow transplanted from donors who are not HLA-identical siblings.
Source Information
Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
This article has been cited by other articles:
Xu, H., Yan, J., Huang, Y., Chilton, P. M., Ding, C., Schanie, C. L., Wang, L., Ildstad, S. T.
(2008). Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Blood
111: 3266-3275
[Abstract][Full Text]
Taylor, P. A., Ehrhardt, M. J., Roforth, M. M., Swedin, J. M., Panoskaltsis-Mortari, A., Serody, J. S., Blazar, B. R.
(2007). Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood
109: 1307-1315
[Abstract][Full Text]
Takahashi, S., Ooi, J., Tomonari, A., Konuma, T., Tsukada, N., Oiwa-Monna, M., Fukuno, K., Uchiyama, M., Takasugi, K., Iseki, T., Tojo, A., Yamaguchi, T., Asano, S.
(2007). Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood
109: 1322-1330
[Abstract][Full Text]
Wehler, T. C., Nonn, M., Brandt, B., Britten, C. M., Grone, M., Todorova, M., Link, I., Khan, S. A., Meyer, R. G., Huber, C., Hartwig, U. F., Herr, W.
(2007). Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines. Blood
109: 365-373
[Abstract][Full Text]
Yakoub-Agha, I., Mesnil, F., Kuentz, M., Boiron, J. M., Ifrah, N., Milpied, N., Chehata, S., Esperou, H., Vernant, J.-P., Michallet, M., Buzyn, A., Gratecos, N., Cahn, J. Y., Bourhis, J. H., Chir, Z., Raffoux, C., Socie, G., Golmard, J. L., Jouet, J.-P.
(2006). Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen-Identical Siblings Versus Human Leukocyte Antigen-Allelic-Matched Unrelated Donors (10/10) in Patients With Standard-Risk Hematologic Malignancy: A Prospective Study From the French Society of Bone Marrow Transplantation and Cell Therapy. JCO
24: 5695-5702
[Abstract][Full Text]
Nguyen, S., Dhedin, N., Vernant, J.-P., Kuentz, M., Jijakli, A. A., Rouas-Freiss, N., Carosella, E. D., Boudifa, A., Debre, P., Vieillard, V.
(2005). NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood
105: 4135-4142
[Abstract][Full Text]
Sanders, J. E., Im, H. J., Hoffmeister, P. A., Gooley, T. A., Woolfrey, A. E., Carpenter, P. A., Andrews, R. G., Bryant, E. M., Appelbaum, F. R.
(2005). Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood
105: 3749-3756
[Abstract][Full Text]
Dainiak, N, Ricks, R C
(2005). The evolving role of haematopoietic cell transplantation in radiation injury: potentials and limitations. Br. J. Radiol.
Supplement_27: 169-174
[Abstract][Full Text]
Ichinohe, T., Uchiyama, T., Shimazaki, C., Matsuo, K., Tamaki, S., Hino, M., Watanabe, A., Hamaguchi, M., Adachi, S., Gondo, H., Uoshima, N., Yoshihara, T., Hatanaka, K., Fujii, H., Kawa, K., Kawanishi, K., Oka, K., Kimura, H., Itoh, M., Inukai, T., Maruya, E., Saji, H., Kodera, Y., for the Japanese Collaborative Study Group for NIM,
(2004). Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood
104: 3821-3828
[Abstract][Full Text]
Petersdorf, E. W., Anasetti, C., Martin, P. J., Gooley, T., Radich, J., Malkki, M., Woolfrey, A., Smith, A., Mickelson, E., Hansen, J. A.
(2004). Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood
104: 2976-2980
[Abstract][Full Text]
Kanda, Y., Chiba, S., Hirai, H., Sakamaki, H., Iseki, T., Kodera, Y., Karasuno, T., Okamoto, S., Hirabayashi, N., Iwato, K., Maruta, A., Fujimori, Y., Furukawa, T., Mineishi, S., Matsuo, K., Hamajima, N., Imamura, M.
(2003). Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood
102: 1541-1547
[Abstract][Full Text]
Ottinger, H. D., Ferencik, S., Beelen, D. W., Lindemann, M., Peceny, R., Elmaagacli, A. H., Husing, J., Grosse-Wilde, H.
(2003). Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood
102: 1131-1137
[Abstract][Full Text]
Grewal, S. S., Barker, J. N., Davies, S. M., Wagner, J. E.
(2003). Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood
101: 4233-4244
[Full Text]
Shimazaki, C., Ochiai, N., Uchida, R., Okano, A., Fuchida, S.-i., Ashihara, E., Inaba, T., Fujita, N., Maruya, E., Nakagawa, M.
(2003). Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood
101: 3334-3336
[Abstract][Full Text]
Castro-Malaspina, H., Harris, R. E., Gajewski, J., Ramsay, N., Collins, R., Dharan, B., King, R., Deeg, H. J.
(2002). Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood
99: 1943-1951
[Abstract][Full Text]
Woolfrey, A. E., Anasetti, C., Storer, B., Doney, K., Milner, L. A., Sievers, E. L., Carpenter, P., Martin, P., Petersdorf, E., Appelbaum, F. R., Hansen, J. A., Sanders, J. E.
(2002). Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood
99: 2002-2008
[Abstract][Full Text]
Walters, M. C., Nienhuis, A. W., Vichinsky, E.
(2002). Novel Therapeutic Approaches in Sickle Cell Disease. ASH Education Book
2002: 10-34
[Abstract][Full Text]
Petersdorf, E. W., Hansen, J. A., Martin, P. J., Woolfrey, A., Malkki, M., Gooley, T., Storer, B., Mickelson, E., Smith, A., Anasetti, C.
(2001). Major-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation. NEJM
345: 1794-1800
[Abstract][Full Text]
Luznik, L., Jalla, S., Engstrom, L. W., Iannone, R., Fuchs, E. J.
(2001). Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood
98: 3456-3464
[Abstract][Full Text]
Umemura, A., Morita, H., Chang Li, X., Tahan, S., Monaco, A. P., Maki, T.
(2001). Dissociation of Hemopoietic Chimerism and Allograft Tolerance After Allogeneic Bone Marrow Transplantation. J. Immunol.
167: 3043-3048
[Abstract][Full Text]
Sugiura, K., Hisha, H., Ishikawa, J., Adachi, Y., Taketani, S., Lee, S., Nagahama, T., Ikehara, S.
(2001). Major Histocompatibility Complex Restriction Between Hematopoietic Stem Cells and Stromal Cells In Vitro. Stem Cells
19: 46-58
[Abstract][Full Text]
Davies, S. M., Kollman, C., Anasetti, C., Antin, J. H., Gajewski, J., Casper, J. T., Nademanee, A., Noreen, H., King, R., Confer, D., Kernan, N. A.
(2000). Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program. Blood
96: 4096-4102
[Abstract][Full Text]
Colson, Y. L., Schuchert, M. J., Ildstad, S. T.
(2000). The Abrogation of Allosensitization Following the Induction of Mixed Allogeneic Chimerism. J. Immunol.
165: 637-644
[Abstract][Full Text]
Spitzer, T. R.
(2000). Nonmyeloablative Allogeneic Stem Cell Transplant Strategies and the Role of Mixed Chimerism. The Oncologist
5: 215-223
[Abstract][Full Text]
Godder, K. T., Hazlett, L. J., Abhyankar, S. H., Chiang, K. Y., Christiansen, N. P., Bridges, K. D., Lee, C. G., Geier, S. S., Goon-Johnson, K. S., Gee, A. P., Pati, A. R., Parrish, R. S., Henslee-Downey, P. J.
(2000). Partially Mismatched Related-Donor Bone Marrow Transplantation for Pediatric Patients With Acute Leukemia: Younger Donors and Absence of Peripheral Blasts Improve Outcome. JCO
18: 1856-1866
[Abstract][Full Text]
McGlave, P. B., Shu, X. O., Wen, W., Anasetti, C., Nademanee, A., Champlin, R., Antin, J. H., Kernan, N. A., King, R., Weisdorf, D. J.
(2000). Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program. Blood
95: 2219-2225
[Abstract][Full Text]
Green, A., Clarke, E., Hunt, L., Canterbury, A., Lankester, A., Hale, G., Waldmann, H., Goodman, S., Cornish, J. M., Marks, D. I., Steward, C. G., Oakhill, A., Pamphilon, D. H.
(1999). Children With Acute Lymphoblastic Leukemia Who Receive T-Cell-Depleted HLA Mismatched Marrow Allografts From Unrelated Donors Have an Increased Incidence of Primary Graft Failure but a Similar Overall Transplant Outcome. Blood
94: 2236-2246
[Abstract][Full Text]
Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A. R., Berkowitz, R. L., Cabbad, M., Dobrila, N. L., Taylor, P. E., Rosenfield, R. E., Stevens, C. E.
(1998). Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors. NEJM
339: 1565-1577
[Abstract][Full Text]
Woolfrey, A. E., Gooley, T. A., Sievers, E. L., Milner, L. A., Andrews, R. G., Walters, M., Hoffmeister, P., Hansen, J. A., Anasetti, C., Bryant, E., Appelbaum, F. R., Sanders, J. E.
(1998). Bone Marrow Transplantation for Children Less Than 2 Years of Age With Acute Myelogenous Leukemia or Myelodysplastic Syndrome. Blood
92: 3546-3556
[Abstract][Full Text]
Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., Reisner, Y., Martelli, M. F., Felicini, R., Falcinelli, F., Carotti, A., Perruccio, K., Ballanti, S., Santucci, A., Gambelunghe, C.
(1998). Treatment of High-Risk Acute Leukemia with T-Cell-Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype. NEJM
339: 1186-1193
[Abstract][Full Text]
Drobyski, W. R., Majewski, D., Ozker, K., Hanson, G.
(1998). Ex Vivo Anti-CD3 Antibody-Activated Donor T Cells Have a Reduced Ability to Cause Lethal Murine Graft-Versus-Host Disease but Retain Their Ability to Facilitate Alloengraftment. J. Immunol.
161: 2610-2619
[Abstract][Full Text]
Dey, B. R., Yang, Y.-G., Szot, G. L., Pearson, D. A., Sykes, M.
(1998). Interleukin-12 Inhibits Graft-Versus-Host Disease Through an Fas-Mediated Mechanism Associated With Alterations in Donor T-Cell Activation and Expansion. Blood
91: 3315-3322
[Abstract][Full Text]
Bernstein, S. H., Nademanee, A. P., Vose, J. M., Tricot, G., Fay, J. W., Negrin, R. S., DiPersio, J., Rondon, G., Champlin, R., Barnett, M. J., Cornetta, K., Herzig, G. P., Vaughan, W., Geils, G. Jr, Keating, A., Messner, H., Wolff, S. N., Miller, K. B., Linker, C., Cairo, M., Hellmann, S., Ashby, M., Stryker, S., Nash, R. A.
(1998). A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation. Blood
91: 3509-3517
[Abstract][Full Text]
Beelen, D. W., Ottinger, H. D., Elmaagacli, A., Scheulen, B., Basu, O., Kremens, B., Havers, W., Grosse-Wilde, H., Schaefer, U. W.
(1997). Transplantation of Filgrastim-Mobilized Peripheral Blood Stem Cells From HLA-Identical Sibling or Alternative Family Donors in Patients With Hematologic Malignancies: A Prospective Comparison on Clinical Outcome, Immune Reconstitution, and Hematopoietic Chimerism. Blood
90: 4725-4735
[Abstract][Full Text]
Torok-Storb, B., Boeckh, M., Hoy, C., Leisenring, W., Myerson, D., Gooley, T.
(1997). Association of Specific Cytomegalovirus Genotypes With Death From Myelosuppression After Marrow Transplantation. Blood
90: 2097-2102
[Abstract][Full Text]
Henslee-Downey, P. J., Abhyankar, S. H., Parrish, R. S., Pati, A. R., Godder, K. T., Neglia, W. J., Goon-Johnson, K. S., Geier, S. S., Lee, C. G., Gee, A. P.
(1997). Use of Partially Mismatched Related Donors Extends Access to Allogeneic Marrow Transplant. Blood
89: 3864-3872
[Abstract][Full Text]
Petersdorf, E. W., Longton, G. M., Anasetti, C., Mickelson, E. M., McKinney, S. K., Smith, A. G., Martin, P. J., Hansen, J. A.
(1997). Association of HLA-C Disparity With Graft Failure After Marrow Transplantation From Unrelated Donors. Blood
89: 1818-1823
[Abstract][Full Text]
Forte, K. J.
(1997). Alternative Donor Sources in Pediatric Bone Marrow Transplantation. Journal of Pediatric Oncology Nursing
14: 213-224
[Abstract]
Hashimoto, F., Sugiura, K., Inoue, K., Ikehara, S.
(1997). Major Histocompatibility Complex Restriction Between Hematopoietic Stem Cells and Stromal Cells In Vivo. Blood
89: 49-54
[Abstract][Full Text]
Petersdorf, E. W., Longton, G. M., Anasetti, C., Mickelson, E. M., Smith, A. G., Martin, P. J., Hansen, J. A.
(1996). Definition of HLA-DQ as a transplantation antigen. Proc. Natl. Acad. Sci. USA
93: 15358-15363
[Abstract][Full Text]
Walters, M. C., Patience, M., Leisenring, W., Eckman, J. R., Scott, J. P., Mentzer, W. C., Davies, S. C., Ohene-Frempong, K., Bernaudin, F., Matthews, D. C., Storb, R., Sullivan, K. M.
(1996). Bone Marrow Transplantation for Sickle Cell Disease. NEJM
335: 369-376
[Abstract][Full Text]
Bensinger, W., Clift, R., Anasetti, C, Appelbaum, F., Demirer, T, Rowley, S, Sandmaier, B., Torok-Storb, B, Storb, R, Buckner, C.
(1996). Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells
14: 90-105
[Abstract]
Kernan, N. A., Bartsch, G., Ash, R. C., Beatty, P. G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J. A., Henslee-Downey, J., McCullough, J., McGlave, P., Perkins, H. A., Phillips, G. L., Sanders, J., Stroncek, D., Thomas, E. D., Blume, K. G.
(1993). Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program. NEJM
328: 593-602
[Abstract][Full Text]
